Titre : Catéchine

Catéchine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cognition
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Catéchine : Questions médicales les plus fréquentes", "headline": "Catéchine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Catéchine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-14", "dateModified": "2025-02-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Catéchine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Flavonoïdes", "url": "https://questionsmedicales.fr/mesh/D005419", "about": { "@type": "MedicalCondition", "name": "Flavonoïdes", "code": { "@type": "MedicalCode", "code": "D005419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450" } } }, "about": { "@type": "MedicalCondition", "name": "Catéchine", "alternateName": "Catechin", "code": { "@type": "MedicalCode", "code": "D002392", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jae Sik Yu", "url": "https://questionsmedicales.fr/author/Jae%20Sik%20Yu", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea." } }, { "@type": "Person", "name": "Ki Hyun Kim", "url": "https://questionsmedicales.fr/author/Ki%20Hyun%20Kim", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea." } }, { "@type": "Person", "name": "Masaharu Shin-Ya", "url": "https://questionsmedicales.fr/author/Masaharu%20Shin-Ya", "affiliation": { "@type": "Organization", "name": "Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan." } }, { "@type": "Person", "name": "Eriko Ohgitani", "url": "https://questionsmedicales.fr/author/Eriko%20Ohgitani", "affiliation": { "@type": "Organization", "name": "Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan." } }, { "@type": "Person", "name": "Masaya Kawamoto", "url": "https://questionsmedicales.fr/author/Masaya%20Kawamoto", "affiliation": { "@type": "Organization", "name": "Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The use of subjective cognitive complaints for detecting mild cognitive impairment in older adults across cultural and linguistic groups: A comparison of the Cognitive Function Instrument to the Montreal Cognitive Assessment.", "datePublished": "2022-10-12", "url": "https://questionsmedicales.fr/article/36222321", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/alz.12804" } }, { "@type": "ScholarlyArticle", "name": "The impact of boarding schools on the development of cognitive and non-cognitive abilities in adolescents.", "datePublished": "2023-09-23", "url": "https://questionsmedicales.fr/article/37742020", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-023-16748-8" } }, { "@type": "ScholarlyArticle", "name": "Monitoring cognitive function in the fatigued warfighter: A rapid review of cognitive biomarkers.", "datePublished": "2023-05-06", "url": "https://questionsmedicales.fr/article/37236820", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jsams.2023.04.009" } }, { "@type": "ScholarlyArticle", "name": "Conceptualizations of aging and cognitive competence: Evaluations and accounts after cognitive testing.", "datePublished": "2022-11-09", "url": "https://questionsmedicales.fr/article/36462919", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaging.2022.101074" } }, { "@type": "ScholarlyArticle", "name": "Validation of the cognitive performance scale of the interRAI-PAC and montreal cognitive assessment.", "datePublished": "2022-08-29", "url": "https://questionsmedicales.fr/article/36039029", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/nop2.1337" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Benzopyranes", "item": "https://questionsmedicales.fr/mesh/D001578" }, { "@type": "ListItem", "position": 6, "name": "4H-1-Benzopyran-4-ones", "item": "https://questionsmedicales.fr/mesh/D002867" }, { "@type": "ListItem", "position": 7, "name": "Flavonoïdes", "item": "https://questionsmedicales.fr/mesh/D005419" }, { "@type": "ListItem", "position": 8, "name": "Catéchine", "item": "https://questionsmedicales.fr/mesh/D002392" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Catéchine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Catéchine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Catéchine", "description": "Comment mesurer les niveaux de catéchines dans le corps ?\nQuels tests sont utilisés pour évaluer l'impact des catéchines ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Cognition&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Catéchine", "description": "Quels sont les effets secondaires des catéchines ?\nLes catéchines provoquent-elles des allergies ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Cognition&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Catéchine", "description": "Les catéchines aident-elles à prévenir les maladies cardiaques ?\nComment intégrer les catéchines dans l'alimentation ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Cognition&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Catéchine", "description": "Les catéchines peuvent-elles traiter des maladies ?\nComment les catéchines aident-elles à la perte de poids ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Cognition&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Catéchine", "description": "Les catéchines peuvent-elles interagir avec des médicaments ?\nQuels risques sont associés à une consommation excessive de catéchines ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Cognition&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Catéchine", "description": "Qui devrait éviter les catéchines ?\nLes femmes enceintes peuvent-elles consommer des catéchines ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Cognition&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment mesurer les niveaux de catéchines dans le corps ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de catéchines peuvent être mesurés par des analyses sanguines ou urinaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'impact des catéchines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests cliniques et des études d'observation sont utilisés pour évaluer leur impact." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des catéchines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des maux d'estomac, des nausées ou des maux de tête." } }, { "@type": "Question", "name": "Les catéchines provoquent-elles des allergies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les allergies aux catéchines sont rares, mais peuvent survenir chez certaines personnes." } }, { "@type": "Question", "name": "Les catéchines aident-elles à prévenir les maladies cardiaques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent réduire le risque de maladies cardiaques en améliorant la santé vasculaire." } }, { "@type": "Question", "name": "Comment intégrer les catéchines dans l'alimentation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Consommer du thé vert, des fruits et des légumes riches en catéchines est recommandé." } }, { "@type": "Question", "name": "Les catéchines peuvent-elles traiter des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont étudiées pour leur potentiel dans le traitement de maladies comme le cancer." } }, { "@type": "Question", "name": "Comment les catéchines aident-elles à la perte de poids ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent augmenter le métabolisme et favoriser la combustion des graisses." } }, { "@type": "Question", "name": "Les catéchines peuvent-elles interagir avec des médicaments ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent interagir avec certains médicaments, notamment les anticoagulants." } }, { "@type": "Question", "name": "Quels risques sont associés à une consommation excessive de catéchines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une consommation excessive peut entraîner des problèmes hépatiques ou des troubles digestifs." } }, { "@type": "Question", "name": "Qui devrait éviter les catéchines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des problèmes hépatiques ou des allergies doivent être prudentes." } }, { "@type": "Question", "name": "Les femmes enceintes peuvent-elles consommer des catéchines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles doivent consulter un médecin avant de consommer des catéchines en grande quantité." } } ] } ] }

Sources (10000 au total)

The use of subjective cognitive complaints for detecting mild cognitive impairment in older adults across cultural and linguistic groups: A comparison of the Cognitive Function Instrument to the Montreal Cognitive Assessment.

This pilot study aims to explore the psychometric properties of the Cognitive Function Instrument (CFI) as a measure of subjective cognitive complaints (SCC) and its performance in distinguishing mild... One hundred ninety-four community-dwelling non-demented older adults with racial/ethnic diversity were included. Unidimensionality and internal consistency of the CFI were examined using factor analys... The CFI demonstrated adequate internal consistency; however, the fit for a unidimensional model was suboptimal. The CFI distinguished MCI from NC alone or in combination with MoCA. ROC analysis showed... Our findings support the use of CFI as a brief and easy-to-use screen to detect MCI in culturally/linguistically diverse older adults.... What is the key scientific question or problem of central interest of the paper? Subjective cognitive complaints (SCCs) are considered the earliest sign of dementia in older adults. However, it is unc...

The impact of boarding schools on the development of cognitive and non-cognitive abilities in adolescents.

Since China adopted a policy to eliminate rural learning centers, boarding has become an important feature of the current rural student community. However, there is a lack of consensus on the impact o... Using a sample of 5,660 seventh-grade students from 160 rural junior high schools across 19 counties, we identify a causal relationship between boarding and student abilities with the instrumental var... The results suggest that boarding positively influences memory and attention, while it has no significant effect on other cognitive abilities such as reasoning, transcription speed, and accuracy. Furt... Given the widespread prevalence of boarding schools in rural regions, our study highlights the growing importance of improving school management to promote the development of students' cognitive abili...

Monitoring cognitive function in the fatigued warfighter: A rapid review of cognitive biomarkers.

Decreases in cognitive function impair occupational performance, reduce occupational safety, and increase musculoskeletal injury risk. The aim of this paper was to identify measures that may be used t... A rapid review.... A rapid search of Academic Search Complete, MEDLINE, PsycINFO, and SPORTSDiscus databases was conducted.... original peer reviewed research articles, written in English, published between 2002 and 2022, and using human participants with no health issues in military training environments or active service.... Of the 248 articles screened, 58 full-text articles were assessed for eligibility and 29 included in the review. Of these, 16 papers presented data from multi-stressor military training environments, ... Prolonged exposure to high-stress military environments compromises multiple aspects of cognitive function. These findings highlight the need for a suite of biomarkers to monitor cognitive function an...

Conceptualizations of aging and cognitive competence: Evaluations and accounts after cognitive testing.

To investigate how conceptualizations of cognition and aging are displayed through evaluations and accounts after cognitive testing with elders who do not have dementia.... 14 persons >65 years of age without clinical memory loss were tested with the MMSE and interviewed about their experiences. The audio-recordings were transcribed according to Conversation Analytic con... The results show how the interviewer and participant being tested evaluate and account for face threats related to the cognitive and communicative competence of the person being tested. Examples of ev... Inviting participants to share their experiences of cognitive testing can reveal valuable information on how they conceptualize cognition and aging, as well as the testing process itself. Reflections ...

Validation of the cognitive performance scale of the interRAI-PAC and montreal cognitive assessment.

The Cognitive Performance Scale (CPS), a minimum data set instrument of the interRAI, was initially designed to evaluate cognition in residential care and has demonstrated strong diagnostic accuracy. ... Mixed methods.... The observational study was conducted in rehabilitation wards. Diagnostic accuracy was used to explore the level of agreement between CPS and Montreal Cognitive Assessment (MoCA) in 321 inpatients (62... The diagnostic accuracy of the CPS was poor when MoCA was less than 24 as a gold standard, with an area under the curve of 0.69 (standard error 0.03, 95% confidence interval = 0.62-0.75). The CPS had ...

Baseline Predictors of Longitudinal Cognitive Outcomes in Persons with Mild Cognitive Impairment.

The study aimed to explore longitudinal cognitive outcomes and to ascertain predictors of conversion to dementia in a hospital-based mild cognitive impairment (MCI) cohort classified according to the ... Subjects aged >55 years who had a clinical diagnosis of MCI at initial visit between 2010 and 2018, with at least one formal neuropsychological assessment at baseline and follow-up of a minimum of ... Ninety-five patients with MCI met the inclusion criteria with a mean age of 68.4 ± 6.4 years at baseline and a mean duration of follow-up for 6.4 ± 3.2 years. The cumulative conversion rate to dementi... There was a higher risk of conversion associated with multidomain MCI. Logistic regression-based estimations of dementia risk utilizing domain-based neuropsychology test scores in MCI have high specif...

Cognitive reserve as a moderating factor between EDSS and cognition in multiple sclerosis.

It is now well recognized that brain damage and/or atrophy apparent on MRI is only moderately correlated to cognitive functioning. The cognitive reserve (CR) hypothesis has been proposed to explain th... A neuropsychological evaluation was performed on 84 pwMS aged between 27 and 78 years old and the CR Index questionnaire (CRIq) was used to estimate CR. The EDSS scale was used to assess the degree of... A moderating effect of CR was observed in the relationship between EDSS score and specific cognitive domains: processing efficiency, visuospatial learning and memory, as well as a tendency for verbal ... The results support the protective role of CR in a sample of pwMS with a wide age range. This role seems to be limited to specific cognitive tasks that pose a greater challenge and therefore require g...